1Shepherd J,Blauw GJ,Murphy MB,Bollen EL,et al.PROSPER study group.Pravastatin in elderly individuals at risk of vascular disease(PROSPER): a randomized controlled trial. PROspective Study of Pravastatin in the Elderly at Risk[].The Lancet.2002 被引量：1
2Sever PS,Dahlof B,Poulter NR,et al.Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations,in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm( ASCOT-LLA): a multicentre randomized[].The Lancet.2003 被引量：1
3Cannon CP,Braunwald E,McCabe CH,et al.Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Investigators.Intensive versus moderate lipid lowering with statins after acute coronary syndromes[].The New England Journal of Medicine.2004 被引量：1
4Heart Protection Study Collaborative Group.MRC BHF heart protection study of cholesterol lowering with simvastation in 20 536 high-risk individuals: a randomized placebo-controlled trial[].The Lancet.2002 被引量：1
5ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group.The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: the Antihypertensive and Lipid-Lowering Treatment to Prevent[].The Journal of The American Medical Association.2002 被引量：1
